Patrick Soon-Shiong

Los Angeles, CA, United States of America

Patrick Soon-Shiong

USPTO Granted Patents = 441 

 

 

Average Co-Inventor Count = 1.9

ph-index = 48

Forward Citations = 7,485(Granted Patents)

Forward Citations (Not Self Cited) = 5,638(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Malibu, CA (US) (2002)
  • Culver, CA (US) (2021)
  • San Diego, CA (US) (2020 - 2023)
  • Los Angeles, CA (US) (1994 - 2024)
  • Culver City, CA (US) (2016 - 2024)
  • Culver City, CO (US) (2024)

Company Filing History:

goldMedal235 out of 547 
 
Nant Holdingsip, LLC
 patents
silverMedal44 out of 80 
 
Abraxis Bioscience, LLC
 patents
bronzeMedal25 out of 63 
 
Nantomics, LLC
 patents
425 out of 52 
 
Immunitybio, Inc.
 patents
525 out of 42 
 
Nantcell, Inc.
 patents
617 out of 52 
 
Nantbio, Inc.
 patents
716 out of 42 
 
Nanthealth, Inc.
 patents
815 out of 17 
 
Vivorx Pharmaceuticals, Inc.
 patents
914 out of 15 
 
Vivorx, Inc.
 patents
109 out of 9 
 
Calcean Minerals and Materials, LLC
 patents
118 out of 19 
 
Nantmobility, LLC
 patents
127 out of 7 
 
American Bioscience, Inc.
 patents
136 out of 10 
 
Nantstudios, LLC
 patents
145 out of 9 
 
Nantworks, LLC
 patents
154 out of 9 
 
Nantbioscience, Inc.
 patents
164 out of 17 
 
Nantkwest Inc.
 patents
174 out of 10 
 
Five3 Genomics, LLC
 patents
183 out of 3 
 
Nantmedia Holdings, LLC
 patents
192 out of 2 
 
Chan Soon-shiong Nanthealth Foundation
 patents
202 out of 61 
 
Altor Bioscience Corporation
 patents
212 out of 47 
 
Tensorcom, Inc.
 patents
221 out of 1 
 
Clover Consolidated, Ltd.
 patent
231 out of 3 
 
Neocrin Company
 patents
241 out of 1 
 
Nant Holdigns Ip, LLC
 patent
251 out of 2 
 
Nani Holdings Ip, LLC
 patents
261 out of 2 
 
Packetfabric, LLC
 patents
271 out of 15 
 
Nanocav, LLC
 patents
281 out of 1 
 
Nanl Holdings Ip, LLC
 patent
291 out of 1 
 
Nantg Power, LLC
 patent
301 out of 2 
 
Abraxis Biosciences, LLC
 patents
311 out of 3 
 
Viracta Therapeutics Inc.
 patents
3219 out of 832,718 
Other
 patents
where one patent can have more than one assignee

Years Active: 1994-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Distributed Ledger
Digital Tokens
Blockchain Management
Healthcare Object Recognition
Multi-Sensor Data Stream
Drone Payload Management
Augmented Reality
Machine Learning Models
Content Authentication
Location-Based Services
Personal Transport Vehicles
Beverage Compositions
441 patents (USPTO):Explore Patents

Title: Patrick Soon-Shiong: Innovator and Prolific Patent Holder

Introduction:

Patrick Soon-Shiong, a renowned entrepreneur and inventor based in Los Angeles, CA, has made significant contributions to the fields of technology, healthcare, and content production. With an impressive patent portfolio and a history of successful ventures, Soon-Shiong has cemented his place as one of the leading innovators in his industry. This article delves into his latest patents, career highlights, notable collaborations, and the impact of his work.

Latest Patents:

Among the numerous patents credited to Patrick Soon-Shiong, two recent innovations stand out. The first patent, "Distributed Command Execution in Multi-Location Studio Environments," focuses on a content production management system. This system enables synchronized execution of commands across various content production entities within a distributed studio environment, improving efficiency and streamlining workflows.

Another noteworthy patent is "Modified NK-92 haNK003 Cells for the Clinic." This invention presents modified populations of NK-92 cells, along with relevant compositions and kits. These modified cells hold immense potential for clinical applications, offering promising methods for their production and utilization.

Career Highlights:

Patrick Soon-Shiong has an extensive career, with notable positions in influential companies. He co-founded and currently serves as Chairman and CEO of Nant Holdingsip, LLC (previously known as NantHealth). Nant Holdingsip is a healthcare technology company that focuses on incorporating data-driven solutions to empower personalized medicine.

Another significant organization Soon-Shiong has been associated with is Abraxis BioScience, LLC (now part of Celgene Corporation). As a founder and CEO of Abraxis BioScience, he played a crucial role in pioneering novel cancer treatments that combined chemotherapy agents with nanoparticle-based delivery mechanisms.

Collaborations:

Throughout his career, Patrick Soon-Shiong has collaborated with experts in various fields to drive innovation. One notable collaborator is Neil P Desai, who has worked alongside Soon-Shiong in developing groundbreaking healthcare technologies and enhancing patient care. Paul A Sandford is another individual who has collaborated with Soon-Shiong, contributing to his innovative projects and entrepreneurial endeavors.

Conclusion:

Patrick Soon-Shiong's prolific patent portfolio, successful career ventures, and fruitful collaborations highlight his significant contributions to technology, healthcare, and content production. His inventions and innovations have the potential to shape industries, enhance efficiency, and improve patient care. As an eminent figure in the innovation landscape, Soon-Shiong continues to inspire and make a lasting impact with his visionary approach and dedication to pushing the boundaries of what is possible.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…